Goodbye 2018

  Moderna CEO says data for Omicron-specific shot likely available in March FILE PHOTO: Moderna's coronavirus disease (COVID-19) vaccine at the Bathgate Post Office vaccination facility in the Bronx, New ork Mon, January 17, 2022, 5:05 AM (Reuters) - Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday. "The vaccine is being finished ... it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps," Bancel said at the World Economic Forum's virtual Davos Agenda conference. Moderna is also developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot. (https://reut.rs/3FAeyya) Bancel said the best case scenario was the combined COVID/flu vaccine w...

  Israel study: 4th vaccine shows limited results with omicron   0:01   1:42    FORECAST COMING UP IN OUR   . SHWELL, OMICRON IS HITTING   DIFFERENT PARTS OF THE COUNTRY   AT DIFFERENT TIMES. AS BRITT   CONWAY REPORTS, THE U.S.  Scroll back up to restore default view. JOSEF FEDERMAN Mon, January 17, 2022, 10:21 AM JERUSALEM (AP) — An Israeli hospital on Monday said preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited defense against the omicron variant that is raging around the world. Sheba Hospital last month began administering a fourth vaccine to more than 270 medical workers — 154 who received a Pfizer-BioNtech vaccine and 120 others who received Moderna's. All had previously been vaccinated three times with the Pfizer-BioNtech vaccine. The clinical trial found that both groups showed increases in antibodies “slightly higher” than following the third vaccine last year. But ...